Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ACE gene insertion/deletion polymorphism: therapeutic implications for ACE inhibitor therapy

June 9, 1999

Japanese advisory committee recommends approval of class III antiarrhythmic

June 8, 1999

Patient treatment completed in pivotal ranolazine trial in angina

June 7, 1999

Pfizer claims PDE1 inhibitors for range of cardiovascular and other disorders

June 7, 1999

First European launch for Tanatril

June 4, 1999

DHA and EPA have differential effects on ambulatory BP and HR in humans

June 2, 1999

Spray formulation of isosorbide dinitrate superior to tablet formulation in hypertensive emergencies

June 2, 1999

Plant-derived compounds significantly reduce BP in hypertensive patients, SHRs

June 1, 1999

CGRP gene transfer successful and effective in rat model of pulmonary hypertension

June 1, 1999

Novel class III antiarrhythmic agents synthesized at Merck

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...